Alignment Healthcare, Inc. $ALHC Shares Bought by Price T Rowe Associates Inc. MD

Key Points

• Price T Rowe Associates Inc. increased its stake in Alignment Healthcare by 9.7%, owning over 2.2 million shares valued at approximately $40.95 million.
• Alignment Healthcare reported a revenue of $1.02 billion for the last quarter, exceeding expectations and marking a 49% year-over-year increase.
• Insider selling has occurred recently, with insiders offloading a total of 636,185 shares valued at around $9.24 million in the last quarter.

Price T Rowe Associates Inc. MD boosted its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 9.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,199,421 shares of the company's stock after buying an additional 193,644 shares during the period. Price T Rowe Associates Inc. MD owned approximately 1.11% of Alignment Healthcare worth $40,954,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in ALHC. MCF Advisors LLC increased its position in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after buying an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in Alignment Healthcare during the 1st quarter valued at about $42,000. Amalgamated Bank increased its position in Alignment Healthcare by 21.6% during the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after buying an additional 616 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after buying an additional 6,286 shares in the last quarter. Finally, Dark Forest Capital Management LP acquired a new position in Alignment Healthcare during the 4th quarter valued at about $150,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Stock Performance

Alignment Healthcare stock traded up $0.28 during midday trading on Tuesday, hitting $16.64. 3,583,120 shares of the company were exchanged, compared to its average volume of 2,623,459. The firm has a market capitalization of $3.30 billion, a PE ratio of -59.43 and a beta of 1.17. Alignment Healthcare, Inc. has a fifty-two week low of $8.65 and a fifty-two week high of $21.06. The business has a fifty day simple moving average of $14.03 and a two-hundred day simple moving average of $15.38. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.14. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare's revenue for the quarter was up 49.0% compared to the same quarter last year. During the same period last year, the company earned ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Activity

In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of the firm's stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $13.44, for a total value of $403,200.00. Following the sale, the president directly owned 2,042,899 shares of the company's stock, valued at approximately $27,456,562.56. This trade represents a 1.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christopher J. Joyce sold 15,491 shares of the firm's stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $16.01, for a total value of $248,010.91. Following the completion of the sale, the insider directly owned 374,531 shares in the company, valued at approximately $5,996,241.31. The trade was a 3.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 636,185 shares of company stock valued at $9,235,468 over the last 90 days. Company insiders own 6.60% of the company's stock.

Analysts Set New Price Targets

ALHC has been the topic of several recent analyst reports. KeyCorp raised Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a research report on Monday, August 25th. Wall Street Zen lowered Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Stephens raised Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Zacks Research raised Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. Finally, Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the company from $9.00 to $13.00 in a report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $18.83.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.